Article Details
Retrieved on: 2022-07-29 20:20:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wee1 competitors including Zentalis might look with trepidation on Astra and Roche's recent moves into ATR inhibition.
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here